Oligoengine is an exclusive RNAi research platform providing design, synthesis, and products focused on novel approaches to gene silencing. With a long history in the field of gene silencing, Oligoengine pioneered Asymmetric RNAi in 2003 by offering products centered around a new portfolio of intellectual property, software and design services.
The 11,000+ researchers in the Oligoengine network quickly access over 14,000 products unique to the Asymmetric RNAi Platform or request custom designs through the Oligoengine software.
Oligoengine continues to lead innovation in RNAi today with products like Multivalent siRNA, X-miR MicroRNA Repressors, and Asymmetric shRNA. Whether your research involves reverse-genetics, drug discovery, or therapeutics development, Oligoengine has the research products and IP licensing support scalable to your needs.
Company Details
- Founded
- -
- Industry
- Biotechnology
- Website
- http://www.oligoengine.com
Oligoengine Questions
Oligoengine's website is http://www.oligoengine.com
Oligoengine's LinkedIn profile is https://www.linkedin.com/company/oligoengine
Oligoengine's industry is
Biotechnology
Oligoengine's top competitors are
Avalyn Pharma,
Alnylam Pharmaceuticals,
Shape Therapeutics Inc.,
Hexagon Bio,
Trillium Ag,
Sana Biotechnology, Inc.,
Halo-Bio Rnai Therapeutics, Inc..
Oligoengine's categories are Biotechnology
Oligoengine's founding year is 2000
